Language: BG BG
nav.cta
← Back to results
Recruiting Phase 4 2024-513534-38-00

The PHENOSAR trial: Antibiotic treatment of biopsy confirmed phenotypes in sarcoidosis: a proof of concept clinical trial.

Phase 4 – monitoring after market approval
Conditions: sarcoidosis

Sponsor: Sint Antonius Ziekenhuis Stichting

trial.available_in: БГ
Overview
Trial status: Authorised Reduction of sarcoidosis related inflammation.
Who can participate
Age group: 18-64 years, 65+ years Gender: Female, Male Target enrollment: 40 participants
Interventions
DOXICLAT 100 mg comprimidos recubiertos con película
Drug
Azithran 500 mg επικαλυμμένα με λεπτό υμένιο δισκία
Drug
Locations 1
Netherlands (1)
Technical details
Status
Recruiting
Phase
Phase 4
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
13.05.2024
Registry ID
2024-513534-38-00
Source
euclinicaltrials.eu
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.